US Sales (44% of sales) grew 9% YoY on new launches, but declined 9% QoQ (given increasing competition in gRenvela). Sales growth across other key verticals was strong (EU: up 37% YoY, RoW: up 33% YoY) which led to 15% YoY growth in EBITDA.